文献速递重症综合管理与镇静镇痛

门诊普外科术后阿片类镇痛与无阿片类镇痛前瞻性比较的可行性:一项试点随机临床试验

Feasibility of Prospectively Comparing Opioid Analgesia With Opioid-Free Analgesia After Outpatient General Surgery: A Pilot Randomized Clinical Trial.
PubMed 文献 · JAMA Netw Open · 2022-07-01
一句话结论试点RCT表明,在门诊普外科术后开展阿片类镇痛与无阿片类镇痛的全规模RCT是可行的,所有预设可行性标准均达标。

这项在加拿大蒙特利尔2所大学附属医院开展的平行、两组、评估者盲法、实用性试点RCT,于2020年1月29日至9月3日纳入成人门诊腹部(胆囊切除、阑尾切除或疝修补)或乳腺(部分或全乳切除)普外科手术患者,随机1:1接受阿片类镇痛(定时非阿片类药物+爆发痛时阿片类)或无阿片类镇痛(定时非阿片类药物增量及/或加用非阿片类药物处理爆发痛)。15名外科医生全部同意并遵守研究流程;患者合格率73%(95%CI 66%-78%),同意率57%(95%CI 49%-65%),76例随机(阿片类组39例[51%],无阿片类组37例[49%]),75例(99%;95%CI 93%-100%)遵守分配治疗,73例(96%;95%CI 89%-99%)完成30天随访,问卷缺失率37/3724(1%;95%CI 0.7%-1.4%)。所有预设RCT可行性标准均达标,支持开展全规模RCT以指导门诊普外科术后镇痛处方。

要点

  • 15名外科医生全部(100%;95%CI 78%-100%)同意患者入组并遵守研究流程,患者合格率73%(95%CI 66%-78%),同意率57%(95%CI 49%-65%)。
  • 76例随机(阿片类组39例[51%],无阿片类组37例[49%]),75例(99%;95%CI 93%-100%)遵守分配治疗,仅1例随机至无阿片类组的患者接受了阿片类处方。
  • 随机至阿片类组的患者中17例(44%)出院后实际消耗了阿片类药物。
  • 73例(96%;95%CI 89%-99%)完成30天随访,问卷缺失率37/3724(1%;95%CI 0.7%-1.4%)。
  • 所有预设RCT可行性标准均达标,支持开展全规模RCT以提供门诊普外科术后镇痛处方的循证依据。

适用人群与场景

  • 成人患者(年龄≥18岁)接受门诊腹部(胆囊切除、阑尾切除或疝修补)或乳腺(部分或全乳切除)普外科手术。
  • 排除标准:对试验所用药物有禁忌、术前使用阿片类药物、可能影响结局评估的疾病、术中或早期并发症需住院者。

诊断标准与关键阈值

  • 预设RCT可行性标准:外科医生同意率、患者合格率、患者同意率、治疗依从率、失访率、随访数据缺失率。

处置流程与药物剂量

  • 阿片类镇痛组:定时非阿片类药物,爆发痛时使用阿片类药物。
  • 无阿片类镇痛组:定时非阿片类药物增量及/或加用非阿片类药物处理爆发痛。

研究设计与关键结果

  • 平行、两组、评估者盲法、实用性试点RCT,在加拿大蒙特利尔2所大学附属医院开展,2020年1月29日至9月3日入组(末次随访2020年10月2日)。
  • 15名外科医生全部(100%;95%CI 78%-100%)同意患者入组并遵守研究流程;患者合格率73%(95%CI 66%-78%),同意率57%(95%CI 49%-65%)。
  • 76例随机(阿片类组39例[51%],无阿片类组37例[49%]),纳入意向性治疗分析(平均[SD]年龄55.5[14.5]岁;女性50例[66%]);40例(53%)接受腹部手术,36例(47%)接受乳腺手术。
  • 75例(99%;95%CI 93%-100%)遵守分配治疗;1例随机至无阿片类组的患者接受了阿片类处方;随机至阿片类组的患者中17例(44%)出院后消耗阿片类药物。
  • 73例(96%;95%CI 89%-99%)完成30天随访;问卷缺失率37/3724(1%;95%CI 0.7%-1.4%)。
  • 所有预设RCT可行性标准均达标。

证据类型、等级与局限

  • 证据类型:试点随机临床试验(RCT)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该试点RCT结果支持开展全规模RCT,以提供门诊普外科术后镇痛处方的循证依据;原文未据此给出具体临床推荐。

指南或共识出处

  • ClinicalTrials.gov Identifier: NCT04254679。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The overprescription of opioids to surgical patients is recognized as an important factor contributing to the opioid crisis. However, the value of prescribing opioid analgesia (OA) vs opioid-free analgesia (OFA) after postoperative discharge remains uncertain.

OBJECTIVE: To investigate the feasibility of conducting a full-scale randomized clinical trial (RCT) to assess the comparative effectiveness of OA vs OFA after outpatient general surgery.

DESIGN, SETTING, AND PARTICIPANTS: This parallel, 2-group, assessor-blind, pragmatic pilot RCT was conducted from January 29 to September 3, 2020 (last follow-up on October 2, 2020). at 2 university-affiliated hospitals in Montreal, Quebec, Canada. Participants were adult patients (aged ≥18 years) undergoing outpatient abdominal (ie, cholecystectomy, appendectomy, or hernia repair) or breast (ie, partial or total mastectomy) general surgical procedures. Exclusion criteria were contraindications to drugs used in the trial, preoperative opioid use, conditions that could affect assessment of outcomes, and intraoperative or early complications requiring hospitalization.

INTERVENTIONS: Patients were randomized 1:1 to receive OA (around-the-clock nonopioids and opioids for breakthrough pain) or OFA (around-the-clock nonopioids with increasing doses and/or addition of nonopioid medications for breakthrough pain) after postoperative discharge.

MAIN OUTCOMES AND MEASURES: Main outcomes were a priori RCT feasibility criteria (ie, rates of surgeon agreement, patient eligibility, patient consent, treatment adherence, loss to follow-up, and missing follow-up data). Secondary outcomes included pain intensity and interference, analgesic intake, 30-day unplanned health care use, and adverse events. Between-group comparison of outcomes followed the intention-to-treat principle.

RESULTS: A total of 15 surgeons were approached; all (100%; 95% CI, 78%-100%) agreed to have patients recruited and adhered to the study procedures. Rates of patient eligibility and consent were 73% (95% CI, 66%-78%) and 57% (95% CI, 49%-65%), respectively. Seventy-six patients were randomized (39 [51%] to OA and 37 [49%] to OFA) and included in the intention-to-treat analysis (mean [SD] age, 55.5 [14.5] years; 50 [66%] female); 40 (53%) underwent abdominal surgery, and 36 (47%) underwent breast surgery. Seventy-five patients (99%; 95% CI, 93%-100%) adhered to the allocated treatment; 1 patient randomly assigned to OFA received an opioid prescription. Seventeen patients (44%) randomly assigned to OA consumed opioids after discharge. Seventy-three patients (96%; 95% CI, 89%-99%) completed the 30-day follow-up. The rate of missing questionnaires was 37 of 3724 (1%; 95% CI, 0.7%-1.4%). All the a priori RCT feasibility criteria were fulfilled.

CONCLUSIONS AND RELEVANCE: The findings of this pilot RCT support the feasibility of conducting a robust, full-scale RCT to inform evidence-based prescribing of analgesia after outpatient general surgery.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04254679.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Do U, El-Kefraoui C, Pook M, et al. Feasibility of Prospectively Comparing Opioid Analgesia With Opioid-Free Analgesia After Outpatient General Surgery: A Pilot Randomized Clinical Trial. JAMA Netw Open. 2022. PMID: 35849399. doi:10.1001/jamanetworkopen.2022.21430

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。